Studies on the Specificity of the Vaccine Effect Elicited by Inactivated Simian Immunodeficiency Virus

M. P. Cranage, N. Polyanskaya, B. McBride, N. Cook, L. A.E. Ashworth, M. Dennis, A. Baskerville, P. J. Greenaway, T. Corcoran, P. Kitchin, J. Rose, M. Murphey-Corb, R. C. Desrosiers, E. J. Stott, G. H. Farrar

Research output: Contribution to journalArticlepeer-review

68 Scopus citations

Abstract

Inactivated, partially purified simian immunodefiency virus (SIVmac) protected macaques from intravenous challenge with homologous and heterologous strains of SIV that had been grown on human cells but no protection against challenge with monkey peripheral blood mononuclear cell-grown SIVmac was afforded. Human immunodeficiency virus type 1 prepared in an analogous way to the SIVmac vaccine on the C8166 human T cell line protected macaques against challenge with human cell-grown SIVmac. These results suggest that protection may be mediated by xenoimmunization with the vaccine cell substrate proteins. All vaccinated macaques had anti-cell antibodies. Major reactivity to MHC class I antigens was found as well as to a 70-kD protein detectable only under nonreducing conditions.

Original languageEnglish (US)
Pages (from-to)13-22
Number of pages10
JournalAIDS research and human retroviruses
Volume9
Issue number1
DOIs
StatePublished - Jan 1993

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Studies on the Specificity of the Vaccine Effect Elicited by Inactivated Simian Immunodeficiency Virus'. Together they form a unique fingerprint.

Cite this